DD
MM
YYYY

PAGES

DD
MM
YYYY

spot_img

PAGES

Home Blog Page 3468

Qualifications To The Defence of Self-defense

0

Every law in force in every jurisdiction; be it religious or secular law forbids and frowns upon the act of killing another man and this act of killing another man is dealt with the most serious punishment available which is killing the killer in return. But there is only one instance when a person is permitted to kill another person and he will not be punished for it. The only time you are permitted in law to kill another man is in self-defence; i.e. you are in a kill-or-be-killed situation and you killed your attacker in defence of yourself; you just have to do it to save your own life, ie in the defence of your person or self-defence. 

In the case of Ekeozor V State (2016) LPELR-40951(CA) the court of appeal held that for an accused person to rely on the defence of self-defence, “it must be seen that the life of the accused was so much endangered by the act of your adversary that the only means of escape from imminent death was to kill the attacker”. See the case of Okordudu v state (2014)LPELR -23210(CA)

This legal permission to kill another person has qualifications and these are some of its qualifications;

Firstly, It must be in a kill-or-be-killed situation. This is to say that you are only permitted to kill in the defense of your person or your property. 

Secondly, your response to the attack must be commensurate or equivalent to the force or threat by your attacker. For instance, you are only permitted to defend yourself with a gun or other deadly weapons if someone attacks you with a gun or other deadly weapons but you cannot defend yourself with a gun or with other deadly weapons against an attacker who is only confronting you with a fist or without any weapon. This second qualification therefore implies that your reprisal attack must be commensurate or equivalent to the perceived threat/ attack by your adversary if not you have committed murder if your adversary dies from the reprisal attack and therefore will not be permitted to rely on the defence of self-defence. 

Thirdly, the reprisal attack or response to the attack against your adversary must be immediately or at the moment of the attack. For instance, if someone shoots at you, you must shoot back in that instant for it to amount to self-defence, if you have to wait later or to catch the person unaware before you shoot the person, it is no longer self-defence. Therefore, the response or reprisal attack must be in the heat of the moment for it to qualify as self-defence

 

Nigeria’s $1Trillion GDP by 2030 – How Are We Pursuing It?

1

I expect Nigeria to rebase its GDP in the next 18 months considering the nation has lost the #1 spot as Africa’s largest economy. More so, the nation plans to hit $1 trillion in GDP by 2030.

Today, the GDP is projected by the IMF to be about $253 billion which is a 2X punishment after the Naira lost its value from N430/$ to N1,000/$. Now, I have some questions on how this could be done:

Option 1: Nigeria rebases and arrives at $700 billion in GDP, a 30% premium pre-Naira floating. Then work to grow to $1 trillion!!! (lol).

Option 2: Nigeria focuses on growing the economy, with Naira at N1,000/$ and hope to hit a Naira equivalent of $1 trillion.

Option 3: Nigeria “fights” for Naira and gets it down to N250/$ at the current level.

Options 2 and 3 are largely mutually inclusive as you cannot grow the economy that way without helping the Naira. Looking deeper, it simply means increased productivity in the land. 

All said, which one do you think the government is working on right now for the $1 trillion GDP?

Africa Accounted For Less Than 1% of Global Startup Funding in Q1 2024

0

According to a recent report by research firm Africa: The Big Deal, Africa accounted for less than 1% (-0.5%) of global startup funding in the first quarter (Q1) of 2024.

The continent’s startup funding remains a marginal fraction of global investment flows and experienced a more pronounced decline compared to most other regions in the first quarter (Q1) of 2024.

In terms of Quarter-on-Quarter (QoQ) evolution, start-up funding in Africa contracted slightly, recording-9%) while it grew in the two top regions (+33% in the US and +8% inEurope) and therefore globally (+11%). Meanwhile, Africa still performed better than Asia (-20%) and LatAm in particular (-38%).

On the Year-on-Year report, Africa performed poorly than other continents, with Q1 2024 funding representing just over half of Q1 2023 funding (-47%).  However, globally and across all regions except Europe (+3%), double-digit decrease was also the norm.

Check Out The Total Amount of funding startups raised in Each Region of Q1 2024

The total funding raised by startups globally in Q1 of 2024 reached $58.4%, representing a +11% Quarter-on-Quarter (QoQ) growth.

US:

Startups in this region raised a total sum of $34.2 billion, with a +33% Quarter-on-Quarter growth. Meanwhile it experienced a -21% decline in Year-on-Year (YoY) evolution.

Europe:

Startups in this region raised a total sum of $12.2 billion, with +8% Quarter-on-Quarter (QoQ) growth. It recorded a positive +3% year-on-year (YoY) growth.

Asia:

Startups in this region raised a total sum of $10.2 billion. However it recorded declines in QoQ and YoY, with -20% and -17% respectively.

LatAm:

Startups in this region raised a total sum of $0.5 billion, with -38% recorded on Quarter-on-Quarter growth, with -29% recorded on Year on Year.

Africa:

Startups in the African region performed poorly, raising $0.3 billion in funding and -9% in Quarter-on-Quarter (QoQ) and -47% Year-on-Year.

The report stated that if Q1 2024 funding were compared to the funding heatwave peak (in late 2021/early 2022), start-ups are currently raising 5x times less quarterly than they were when fundraising peaked in Q3 2021.

This highlights a more serious contraction than the global average (3.1x), which is very much influenced by Europe and US numbers (2.7x). It is in line with the Asian trend though, and much less dramatic than the gap registered in LatAm (14x).

Notably, the trajectory of venture funding to African startups is beginning to look like a bell curve from barely anything 10 years ago to a rapid acceleration in 2021, peak funding in 2022, and a deceleration starting from 2023.

For the coming quarters, with global inflation and interest rates still at record highs, there are expectations of similar declines in African startup funding versus the previous year’s equivalent quarter.

African startups have been urged to focus on generating revenue and strengthening financial management amidst the decline in VC funding. Meanwhile, in response to the funding crunch, several startups have implemented several strategic measures to keep their business afloat.

Apart from the downsizing of the workforce, reports reveal that some of these measures implemented varied from business model shifts to exploring asset-light approaches.

Top 5 Crypto Presales of 2024: BlockDAG Leads with $19.8M, Alongside Dogecoin20, 5th Scape, Sponge V2, and eTukTuk

0

The 2024 crypto market is bustling with activity, showcasing several presales that are set to redefine global investment approaches. In the top 5 crypto presales of 2024, leading the pack are BlockDAG (BDAG), Dogecoin20 ($DOGE20), 5th Scape ($5SCAPE), Sponge V2 ($SPONGEV2), and eTukTuk ($TUK). These projects not only offer groundbreaking opportunities but also feature unique innovations.

BlockDAG, in particular, excels with its sophisticated hybrid technology that merges the security features of blockchains with the efficiency of DAG systems, marking a significant evolution in the sector.

1. BlockDAG: Forefront of Hybrid Crypto Technology:

BlockDAG is transforming the crypto space by integrating blockchain with Directed Acyclic Graph (DAG) technology. This fusion enhances transaction speed while upholding the robust security and reliability that blockchain is known for. Having already amassed $19.7 million, BlockDAG aims to reach a fundraising goal of $600 million by 2025.

Starting at a presale price of $0.005, the token’s value is anticipated to soar, offering substantial returns. The project’s momentum is further boosted by recent strategic developments, including a key presentation in Shibuya and the release of a detailed technical whitepaper.

2. Dogecoin20 ($DOGE20): Advancing Meme Coins Sustainably:

Dogecoin20 expands on Dogecoin’s foundation by adopting an eco-friendly Proof-of-Stake protocol, enhancing both the speed and security of transactions while delivering high yields, initially offering an APY of over 1800%.

Starting at $0.00014 per token, Dogecoin20 has quickly secured over $270K in investments, demonstrating solid market interest and backing. Its focus on sustainable cryptocurrency exchanges and attractive staking rewards positions Dogecoin20 as a prime choice for eco-aware investors.

3. Sponge V2 ($SPONGEV2): Meme Coin with New Gaming Features:

Building on $SPONGE’s success, Sponge V2 aims to strengthen its community ties with improved tokenomics and a forthcoming play-to-earn game. Positioned strategically for future listings on major exchanges like Binance and OKX, Sponge V2 is poised for significant market impact. Early backers gain from staking V1 tokens and enjoy enhanced rewards over four years as they transition to V2.

4. eTukTuk ($TUK): Leading the Eco-Friendly Transport Revolution:

eTukTuk is making strides in the electric vehicle (EV) market in developing nations by introducing an economical and environmentally friendly transport option. Its presale has swiftly raised over $1.9 million, highlighting its potential.

Investors not only contribute to a green initiative but can also benefit from the profits generated through $TUK-powered charging stations that provide attractive staking rewards.

5. 5th Scape ($5SCAPE): Pioneering VR on Blockchain:

5th Scape delves into the growing VR market by providing token holders with access to an expansive range of VR services—from gaming to educational content and major cinematic releases. Priced at $0.00248 per token, 5th Scape offers perpetual access to a broadening portfolio of VR services and products, along with discounts on cutting-edge VR gear for its token holders.

Final Call

As we edge closer to a pivotal year in the cryptocurrency sector, these top 5 crypto presales of 2024 offer varied and exciting investment possibilities. Each project stands out for its distinctive strengths, yet BlockDAG clearly leads with its advanced technology and promising growth potential, positioning it as the top investment choice for 2024.

This selection of innovative cryptocurrencies provides diverse options tailored to every investor’s needs, with BlockDAG at the helm as the premier crypto acquisition.

Connect with BlockDAG Now!

Website: https://blockdag.network

Presale: https://purchase.blockdag.network

Telegram: https://t.me/blockDAGnetworkOfficial

Discord: https://discord.gg/Q7BxghMVyu

Tekedia Capital is excited to congratulate Revnabio for its dual ISO accreditations

0

Tekedia Capital is excited to congratulate Revnabio for this milestone: “Revna Biosciences has carved a niche for itself in Ghana and West Africa by being the first facility in the region to secure dual ISO accreditations: ISO 15189:2022 for clinical diagnostics and ISO 20387:2018 for biobanking. This milestone is a testament to RevnaBio’s unwavering commitment to championing precision medicine by propelling molecular diagnostics and therapeutic discovery in the region…..’

“The American Association for Laboratory Accreditation (A2LA) has bestowed the ISO 15189:2022 accreditation upon Revna Biosciences, acknowledging its dedication to delivering top-tier clinical testing services. The accreditation process entailed a rigorous on-site evaluation by A2LA’s assessors, verifying the facility’s compliance with strict standards of precision, reliability, and patient confidentiality.”

We thank the Revnabio Team for the exceptional execution and commend our members for their commitments to fund generation-shaping companies in Africa and beyond.

— press release

ACCRA, Ghana, April 23, 2024/APO Group/ — Revna Biosciences (www.RevnaBio.com) has carved a niche for itself in Ghana and West Africa by being the first facility in the region to secure dual ISO accreditations: ISO 15189:2022 for clinical diagnostics and ISO 20387:2018 for biobanking. This milestone is a testament to RevnaBio’s unwavering commitment to championing precision medicine by propelling molecular diagnostics and therapeutic discovery in the region.

A Pledge to Quality and Patient Care

The American Association for Laboratory Accreditation (A2LA) has bestowed the ISO 15189:2022 accreditation upon Revna Biosciences, acknowledging its dedication to delivering top-tier clinical testing services. The accreditation process entailed a rigorous on-site evaluation by A2LA’s assessors, verifying the facility’s compliance with strict standards of precision, reliability, and patient confidentiality.

Revna Biosciences’ accreditation encompasses an extensive array of human sample tests, including those involving urine, swabs, blood, bone marrow, tissue samples, and plasma. With a specialization in bacteriology, virology, and molecular pathology, the facility is dedicated to providing patients with accurate and dependable diagnoses.

we are dedicated to enhancing access to top-quality healthcare and research facilities, especially in Africa where the demand for such services is paramount

Biobanking Excellence

Revna Biosciences has also earned accreditation for its biobanking practices under ISO 20387:2018. This accreditation spans the entire biospecimen lifecycle, from collection and acquisition to preservation, testing, storage, and distribution of various tissues and blood products. The company’s adherence to international standards guarantees the quality and integrity of biospecimen, thereby contributing to advancements in global medical research.

Dr. Derrick Edem Akpalu, CEO and Co-founder of Revna Biosciences, stated, “Our dual ISO accreditations reflect our commitment to excellence and quality, from sample collection to data analysis. This not only reassures patients but also benefits researchers and industry partners. These accreditations enhance our clinical research services, paving the way for global therapeutics and diagnostics development. By adhering to these ISO standards, we ensure the reliability of our archived biosamples and data, thereby enriching clinicogenomic insights and propelling the advancement of personalized medicine in the region. ”

Dr. Yaw Asare-Aboagye, a board member of the company, added, “We aim to meet the highest international standards as we are dedicated to enhancing access to top-quality healthcare and research facilities, especially in Africa where the demand for such services is paramount.”

Global Recognition and Industry Alignment

A2LA, the accrediting organization, is renowned for its Centers for Medicare and Medicaid Services (CMS) Deemed Status and International Laboratory Accreditation Cooperation (ILAC) Recognition, an indication of its reputation as an accrediting board in global clinical diagnostics. Furthermore, RevnaBio is a member of ISBER, an international forum for biobanking that advocates for high-quality standards and innovation in biorepository management. Revna Biosciences’ achievement aligns with global recognition and industry standards, positioning the company at the vanguard of medical innovation.